Myriad Genetics Supports AMA Launch of Hereditary Cancer Education Program

Myriad Genetics, Inc., has provided an unrestricted educational grant to the American Medical Association that was used to prepare and distribute up to 75,000 physician education modules on hereditary colon cancer, entitled, ``Identifying and Managing Risk for Hereditary Nonpolyposis Colorectal Cancer and Endometrial Cancer (HNPCC),'' the Company announced today. The education modules provide physicians with up to three hours of AMA PRA Category 1 Continuing Medical Education (CME) credit